Robert Michael
Directeur Général chez TOBIRA THERAPEUTICS INC
Fortune : 17 M $ au 30/04/2024
Postes actifs de Robert Michael
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALLERGAN PLC | Directeur/Membre du Conseil | 08/05/2020 | - |
President | 08/05/2020 | - | |
TOBIRA THERAPEUTICS INC | Directeur Général | - | - |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Directeur/Membre du Conseil | - | - |
President | - | - |
Historique de carrière de Robert Michael
Anciens postes connus de Robert Michael
Sociétés | Poste | Début | Fin |
---|
Formation de Robert Michael
Kelley School of Business | Undergraduate Degree |
UCLA Anderson School of Management | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 7 |
Irlande | 2 |
Opérationnelle
Director/Board Member | 4 |
President | 4 |
Chief Operating Officer | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ABBVIE INC. | Health Technology |
ABBOTT LABORATORIES | Health Technology |
Entreprise privées | 3 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Tobira Therapeutics, Inc.
Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on October 6, 2006 and is headquartered in Madison, NJ. | Health Technology |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Health Technology |
- Bourse
- Insiders
- Robert Michael
- Expérience